Showing results (471-480 of 482) with videos related to

Sort By:
Pageof 49
Inflammatory Bowel Diseases|April 26, 2025
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception CohortSimen Hyll Hansen, Maria Gjerstad Maseng, Olle Grännö, et al.
Ecology Letters|January 27, 2021
The influence of vector-borne disease on human history: socio-ecological mechanismsTejas S Athni, Marta S Shocket, Lisa I Couper, et al.
Scandinavian Journal of Gastroenterology|June 22, 2021
Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern NorwayVendel A Kristensen, Randi Opheim, Gøri Perminow, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
BMJ (Clinical Research Ed.)|December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trialMerete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|May 19, 2024
Continuing benefits of the Montreal Protocol and protection of the stratospheric ozone layer for human health and the environmentS Madronich, G H Bernhard, P J Neale, et al.
Cell|May 6, 2017
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and MexicoDavide F Robbiani, Leonia Bozzacco, Jennifer R Keeffe, et al.
BMJ Open|March 20, 2023
Investigating survival, quality of life and cognition in PROton versus photon therapy for <i>IDH-</i>mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and SwedenLiv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, et al.
Journal of Internal Medicine|February 15, 2019
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trialG L Goll, K K Jørgensen, J Sexton, et al.
Pageof 49